Effects of gemfibrozil on insulin sensitivity and on haemostatic variables in hypertriglyceridemic patients

This publication has 58 references indexed in Scilit:

• Effects of gemfibrozil therapy on glucose tolerance, insulin sensitivity and plasma plasminogen activator inhibitor activity in hypertriglyceridaemia
  Journal of Cardiovascular Risk, 1996
• Gemfibrozil treatment of endogenous hypertriglyceridemia: effect on insulin-mediated glucose disposal and plasma insulin concentrations
  Journal of Clinical Endocrinology & Metabolism, 1996
• Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young Age
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
• Insulin action and glucose metabolism are improved by gemfibrozil treatment in hypertriglyceridemic patients
  Atherosclerosis, 1995
• Hypertriglyceridemia and regulation of fibrinolytic activity.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• Altering Triglyceride Concentrations Changes Insulin-Glucose Relationships in Hypertriglyceridemic Patients: Double-Blind Study With Gemfibrozil With Implications for Atherosclerosis
  Diabetes Care, 1991
• Bezafibrate Retard in Type II Diabetic Patients
  Journal of Cardiovascular Pharmacology, 1990
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• The fibrinolytic system and coagulation during bezafibrate treatment of hypertriglyceridemia
  Atherosclerosis, 1986
• Gemfibrozil in the Treatment of Dyslipidaemia A 5‐year follow‐up study
  Acta Medica Scandinavica, 1982